» Articles » PMID: 33725494

Healthcare Indicators Associated with COVID-19 Death Rates in the European Union

Overview
Journal Public Health
Publisher Elsevier
Specialty Public Health
Date 2021 Mar 16
PMID 33725494
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Identification of environmental and hospital indicators that may influence coronavirus disease 2019 (COVID-19) mortality in different countries is essential for better management of this infectious disease.

Study Design: Correlation analysis between healthcare system indicators and COVID-19 mortality rate in Europe.

Methods: For each country in the European Union (EU), the date of the first diagnosed case and the crude death rate for COVID-19 were retrieved from the John Hopkins University website. These data were then combined with environmental, hospital and clinical indicators extracted from the European Health Information Gateway of the World Health Organization.

Results: The COVID-19 death rate in EU countries (mean 1.9 ± 0.8%) was inversely associated with the number of available general hospitals, physicians and nurses. Significant positive associations were also found with the rate of acute care bed occupancy, as well as with the proportion of population who were aged older than 65 years, overweight or who had cancer. Total healthcare expenditure, public sector health expenditure and the number of hospital and acute care beds did not influence COVID-19 death rate.

Conclusions: Some common healthcare system inadequacies, such as limited numbers of general hospitals, physicians and nurses, in addition to high acute care bed occupancy, may be significant drivers of nationwide COVID-19 mortality rates in EU countries.

Citing Articles

Construction and validation of a covariate-based model for district-level estimation of excess deaths due to COVID-19 in India.

Krishnan A, Dubey M, Kumar R, Salve H, Upadhyay A, Gupta V J Glob Health. 2024; 14:05013.

PMID: 38813676 PMC: 11140283. DOI: 10.7189/jogh.14.05013.


Regional Variations in Coronavirus Disease 2019 Mortality in Japan: An Ecological Study.

Nakamura A, Kotani K, Hatakeyama S, Obayashi S, Nagai R JMA J. 2023; 6(4):397-403.

PMID: 37941702 PMC: 10628200. DOI: 10.31662/jmaj.2023-0052.


Does increasing the number of beds or health workers contribute to the rational use of scarce public health resources?.

Cinaroglu S Glob Health Med. 2023; 5(1):23-32.

PMID: 36865894 PMC: 9974230. DOI: 10.35772/ghm.2023.01006.


Improvements throughout the Three Waves of COVID-19 Pandemic: Results from 4 Million Inhabitants of North-West Italy.

Caramello V, Catalano A, Macciotta A, Dansero L, Sacerdote C, Costa G J Clin Med. 2022; 11(15).

PMID: 35893395 PMC: 9332615. DOI: 10.3390/jcm11154304.


The success rate of online illicit drug transactions during a global pandemic.

Bergeron A, Decary-Hetu D, Giommoni L, Villeneuve-Dubuc M Int J Drug Policy. 2021; 99:103452.

PMID: 34597861 PMC: 8500732. DOI: 10.1016/j.drugpo.2021.103452.


References
1.
Teixeira da Silva J, Tsigaris P . Policy determinants of COVID-19 pandemic-induced fatality rates across nations. Public Health. 2020; 187:140-142. PMC: 7434485. DOI: 10.1016/j.puhe.2020.08.008. View

2.
Mesas A, Cavero-Redondo I, Alvarez-Bueno C, Cabrera M, de Andrade S, Sequi-Dominguez I . Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions. PLoS One. 2020; 15(11):e0241742. PMC: 7608886. DOI: 10.1371/journal.pone.0241742. View